100,000+ That’s how many patients participate in our clinical trials at any given time. GCO is Novartis’ powerhouse of Global Clinical Operations, redesigned to enable faster trial recruitment and enhanced trial delivery resulting in more timely access for patients to potential novel treatments. Every day, we are the link between science and medicine – imagine the impact you could have as [Role]! #GCO

Job Purpose:

The Clinical Trial Associate (CTA) supports SSO Study Start-Up Manager and SSO Clinical Project Manager in assigned studies during set-up and whole study lifecycle in compliance with Novartis processes, GCP/ICH and regulatory requirements.

Accountabilities:

• Supports document collection, preparation, and adaption for submission to IRB/EC and Health Authorities as applicable. Sets-up systems. Supports vendor selection, TPRM process, SIM entries.

• IF and TMF management (country and site TMF); set-up and maintenance according to regulatory and Novartis requirements; document oversight and tracking. Supports Vendor set-up as applicable. Checks site “Green Light” completeness and ensures all documentation is in place for initial and subsequent drug release in collaboration with the local Qualified Person(s)

• Supports preparation and translation of ICF into local languages (including vendor management if necessary). Supports preparation of patient facing material. Responsible for completeness of uploaded trial related documents into CREDI/SUBWAY, including archiving of paper TMFs.

• Supports country SSU strategy in close collaboration with SSU Team Lead and SSU Managers to ensure SSU timelines and deliverables are met according to country commitments. Ensures adherence to financial standards, prevailing legislation, ICH/GCP, IRB/IEC, Health Authority and SOP requirements. Provides logistic support to SSU CRA, CRA, CPM, SSU Manager in all phases of the clinical trial.

• Implements innovative and efficient processes which are in line with Novartis strategy
Activities & Interfaces How does this role operate within, interact with and impact the organization.
Interfaces with external vendors and sites to ensure issues resolution as needed.

Key Performance Indicators:

1. Performance against study commitments at the country level, including set-up/delivery of trials as per defined timelines and milestones (IRB/IEC & HA approval, RIS, SIV, system updates, TMF) and data quality requirements.

2. Delivery of study milestones in adherence to prevailing legislation, ICH/GCP, IRB/IEC, Health Authority and SOP requirements

3. Timely submission and delivery of high-quality clinical trial documentation/data

https://www.youtube.com/watch?v=ggbnzRY9z8w.